Investment Overview - Apple is increasing its investment in the U.S. by $100 billion, reaching a total projected investment of $600 billion over the next four years [1][2] - The investment is part of the new American Manufacturing Program (AMP), which aims to enhance advanced manufacturing in the U.S. [2] Job Creation - Apple plans to hire 20,000 people in the U.S., primarily in research and development, silicon engineering, software development, and artificial intelligence and machine learning [2] Partnerships and Manufacturing - Through the AMP, Apple will collaborate with companies such as Corning, GlobalWafers America, Applied Materials, and Texas Instruments [3] - Apple is bringing touchscreen manufacturing to Corning's factory in Kentucky, ensuring that all iPhones and Apple Watches sold globally will feature Kentucky-made cover glass [3] - The company aims to establish an end-to-end silicon supply chain in the United States [3] Facility Expansion - Apple is expanding its U.S. facilities, with new construction projects in Houston and Maiden, North Carolina, to produce servers and enhance data center capacity [4] - Additional data center expansions are underway in Iowa, Nevada, and Oregon [4] Regulatory Context - These investments follow demands from the Trump administration for Apple to relocate manufacturing to the U.S., with threats of a 25% tariff on devices if compliance was not met [5] - The announcement also coincides with a new 25% tariff on goods imported to the U.S. from India, in addition to existing tariffs on Chinese imports [5][6]

Core Insights - Waste Management, Inc. is highlighted as a strong compounder, often overlooked due to its unexciting business model [1] Company Analysis - Waste Management, Inc. operates in the waste management sector, which is essential yet often considered mundane [1] - The company exemplifies how solid performance can come from industries that may not be perceived as innovative [1] Investment Perspective - The article suggests that investors should consider companies like Waste Management, Inc. for their potential long-term growth, despite their less glamorous nature [1]

Core Viewpoint - Hims & Hers Health experienced a significant decline in stock price due to lower revenue expectations from its personalized GLP-1 weight loss medication, leading to a nearly 11% drop in shares on August 5, 2025 [1][3]. Financial Performance - The company's total revenue for Q2 2025 was $545 million, reflecting a 7% sequential decline [3]. - Revenue from compounded GLP-1 weight-loss drugs decreased to $190 million from $230 million in the previous quarter [3]. - Revenue per subscriber fell to $74 from $84, attributed to the off-boarding of some GLP-1 subscribers [3]. Legal Issues - Hims & Hers is facing a securities class action lawsuit related to a terminated collaboration with Novo Nordisk, which was intended to expand access to the FDA-approved weight loss drug Wegovy® [2][5]. - The lawsuit alleges that the company engaged in deceptive promotion and selling of illegitimate versions of Wegovy®, which jeopardized patient safety and led to the termination of the partnership with Novo Nordisk [6]. - Following the announcement of the partnership termination on June 23, 2025, Hims' stock price plummeted over 34% [6]. Business Model Shift - The company has shifted its business model after the FDA ended mass compounding of certain weight-loss drugs, now focusing on personalized, smaller-dose compounded versions [4]. - Hims & Hers previously touted its collaboration with Novo Nordisk but lost it due to regulatory concerns regarding its practices [4].

Core Insights - Axon Enterprise (AXON) and Palantir Technologies (PLTR) have experienced significant stock price increases, with AXON up over 40% year-to-date and PLTR surging more than 130% [1][2] - Both companies have reported strong Q2 results, driven by increased public safety and defense spending [3][8] Axon Enterprise Highlights - Axon reported Q2 sales of $668.54 million, a nearly 33% year-over-year increase, surpassing estimates of $642.98 million by 4% [3] - This marks the 14th consecutive quarter of revenue growth above 25%, with broad demand across its portfolio, including AI services and drones [4] - Q2 earnings per share (EPS) were $2.12, exceeding expectations of $1.54 by 37% and up 76% from $1.20 in the prior period [5] - Axon has exceeded the Zacks EPS Consensus for 33 consecutive quarters, with an average earnings surprise of 25.87% over the last four quarters [5] Palantir Technologies Highlights - Palantir achieved its first billion-dollar quarter with Q2 sales of $1 billion, a 48% increase from $678.13 million a year ago, driven by strong demand for its AI platform [8] - The company secured a $10 billion contract with the U.S. Army, contributing to its growth [8] - Q2 EPS was $0.16, up from $0.09 in the comparative quarter and exceeding expectations of $0.14 [9] - Palantir has exceeded the Zacks EPS Consensus for 11 consecutive quarters, with an average earnings surprise of 13.17% over the last four quarters [10] Full-Year Guidance Updates - Axon raised its fiscal 2025 revenue guidance to $2.65-$2.73 billion, up from $2.6-$2.7 billion, and adjusted EBITDA guidance to $665-$685 million [12] - Palantir increased its FY25 revenue forecast to $4.142 billion-$4.15 billion, up from $3.89 billion-$3.9 billion, with commercial revenue expected to exceed $1 billion [13] Valuation Insights - Axon trades at a price-to-sales (P/S) ratio of 25X, while Palantir's P/S ratio is significantly higher at 104X, indicating Axon may offer better value at current levels [15] - Axon's profitability and earnings estimate revisions suggest it is a more sound investment compared to Palantir, which may not offer much fundamental value after its recent rally [18]

Core Viewpoint - DHT Holdings reported quarterly earnings of $0.24 per share, exceeding the Zacks Consensus Estimate of $0.23 per share, but down from $0.27 per share a year ago, indicating an earnings surprise of +4.35% [1][2] Financial Performance - The company posted revenues of $93.19 million for the quarter ended June 2025, missing the Zacks Consensus Estimate by 0.57%, and down from $103.7 million year-over-year [2] - Over the last four quarters, DHT Holdings has surpassed consensus EPS estimates four times and topped consensus revenue estimates two times [2] Stock Performance - DHT Holdings shares have increased approximately 26.5% since the beginning of the year, significantly outperforming the S&P 500's gain of 7.1% [3] Future Outlook - The company's earnings outlook will be crucial for investors, including current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The current consensus EPS estimate for the coming quarter is $0.13 on revenues of $95.48 million, and for the current fiscal year, it is $0.85 on revenues of $377.31 million [7] Industry Context - The Transportation - Shipping industry, to which DHT Holdings belongs, is currently ranked in the bottom 39% of over 250 Zacks industries, indicating potential challenges ahead [8]

Group 1 - Global stocks are showing solid performance in 2025, but not all countries are achieving extraordinary returns [1] - The iShares MSCI Australia ETF has increased by 10% so far in 2025, yet it has underperformed compared to the EAFE Index [1]

Since my last coverage of Hims & Hers Health (NYSE: HIMS ), its stock has surged by about 24%. After the announcement of the company's Q2'25 earnings report , its pre-market stock price droppedI am an experienced Risk Management Business Analyst at a Systemic Greek Bank, with a strong background in finance and risk analysis. I hold an MSc in Applied Risk Management from the University of Athens and have completed the ACA Certificate Level. My expertise lies in financial analysis, risk management, data analy ...

Blue Owl Capital Corporation (OBDC) reported $485.84 million in revenue for the quarter ended June 2025, representing a year-over-year increase of 22.5%. EPS of $0.40 for the same period compares to $0.48 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $463.85 million, representing a surprise of +4.74%. The company delivered an EPS surprise of +2.56%, with the consensus EPS estimate being $0.39.While investors scrutinize revenue and earnings changes year-over-year and how they co ...

For the quarter ended June 2025, Western Midstream (WES) reported revenue of $942.32 million, up 4.1% over the same period last year. EPS came in at $0.87, compared to $0.97 in the year-ago quarter.The reported revenue represents a surprise of +0.09% over the Zacks Consensus Estimate of $941.48 million. With the consensus EPS estimate being $0.82, the EPS surprise was +6.1%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine ...

For the quarter ended June 2025, The Pennant Group, Inc. (PNTG) reported revenue of $219.5 million, up 30.1% over the same period last year. EPS came in at $0.27, compared to $0.24 in the year-ago quarter.The reported revenue represents a surprise of +3.16% over the Zacks Consensus Estimate of $212.78 million. With the consensus EPS estimate being $0.26, the EPS surprise was +3.85%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wal ...